KidneyCAN(@kidneycan) 's Twitter Profileg
KidneyCAN

@kidneycan

Our mission is to accelerate cures for #kidneycancer. We educate patients about clinical trials, advocate for research funding, and bring researchers together.

ID:1078088347283795968

linkhttps://kidneycan.org calendar_today27-12-2018 00:41:06

4,3K Tweets

2,1K Followers

792 Following

Follow People
Nephrology Times(@Neph_Times) 's Twitter Profile Photo

KidneyCAN Kidney Cancer Research Summit is coming up July 11-12 in Boston. View the program and register now. cancer
👇
kcrs.kidneycan.org

account_circle
Sumanta K. Pal, MD, FASCO(@montypal) 's Twitter Profile Photo

Terrific work! You have been so dedicated to the KIM-1 story, including your recent terrific poster at AACR describing the biomarker in the adjuvant setting via ( / in high-risk localized ). Proud of you for leading this large at important

Terrific work! You have been so dedicated to the KIM-1 story, including your recent terrific poster at @AACR describing the biomarker in the adjuvant setting via #CM914 (#nivolumab/#ipilimumab in high-risk localized #kidneycancer). Proud of you for leading this large at important
account_circle
Emre Yekedüz(@yekeduz_emre) 's Twitter Profile Photo

🧬🧬🧬A must-read comprehensive review on the role of VHL protein signaling in patients with clear cell renal cell carcinoma📖⬇️⬇️⬇️

doi.org/10.1038/s41585…

OncoAlert Nature Medicine @Nature Chengheng Liao

🧬🧬🧬A must-read comprehensive review on the role of VHL protein signaling in patients with clear cell renal cell carcinoma📖⬇️⬇️⬇️ doi.org/10.1038/s41585… @OncoAlert @NatureMedicine @Nature @ChenghengLiao
account_circle
Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo

🌟 Submit your abstracts for KCRS24 by May 6th! Join us at the Kidney Cancer Research Summit to present your work, connect with top experts, and advance kidney cancer research.
📅🔬 Deadline for submission: Monday, May 6th.

🔗 Submit today and be part of advancing kidney cancer

🌟 Submit your abstracts for KCRS24 by May 6th! Join us at the Kidney Cancer Research Summit to present your work, connect with top experts, and advance kidney cancer research. 📅🔬 Deadline for submission: Monday, May 6th. 🔗 Submit today and be part of advancing kidney cancer
account_circle
Qing Zhang(@QingZhangLab) 's Twitter Profile Photo

nature.com/articles/s4158…

Glad to share our latest review on VHL and ccRCC Nature Reviews Urology . Spearheaded by Chengheng Liao in my lab and really appreciate the dedicated efforts from Nature Reviews Urology editorial team that makes this happen.

account_circle
KidneyCAN(@kidneycan) 's Twitter Profile Photo

Congratulations! So very well-deserved! @tompowles's leadership is changing lives for patients with around the world.

Dr. Powles spoke at our February Town Hall (🔗bit.ly/UromigosTownHa…) and is a member of the Leadership Team (🔗kcrs.kidneycan.org).

account_circle
Sid Sadler(@Sid423) 's Twitter Profile Photo

Can’t wait to attend this event from KidneyCAN as a new patient in the kidney cancer arena. Boston would be nice to travel to, but Nashville will have to do 🤣

Can’t wait to attend this event from @kidneycan as a new patient in the kidney cancer arena. Boston would be nice to travel to, but Nashville will have to do 🤣
account_circle
Emre Yekedüz(@yekeduz_emre) 's Twitter Profile Photo

⭐️⭐️⭐️How to implement SABR into the clinical practice in oligometastatic and oligoprogessive RCC‼️

🎯🎯🎯Here the summary of Delphi Consensus:

✅Panellists unanimously agreed to apply no age restrictions (100%) and to consider all primary renal cell carcinoma histologies (92%)

⭐️⭐️⭐️How to implement SABR into the clinical practice in oligometastatic and oligoprogessive RCC‼️ 🎯🎯🎯Here the summary of Delphi Consensus: ✅Panellists unanimously agreed to apply no age restrictions (100%) and to consider all primary renal cell carcinoma histologies (92%)
account_circle
RMC Alliance(@RmcAlliance) 's Twitter Profile Photo

Facing ? You're not alone. Passionate advocates & respected researchers are raising awareness and improving survival rates. Stay tuned as experts work towards doubling survival rates

account_circle
Neeraj Agarwal, MD, FASCO(@neerajaiims) 's Twitter Profile Photo

Just in Cancer Cell 👉Validation of the molecular clusters of the IMmotion151 trial in the JAVELIN Renal 101 dataset : Excellent commentary highlighting these biomarkers by our fellow Chadi Hage Chehade 👇tinyurl.com/48px5rw8 GU Cancer Research Program @HuntsmanCancer OncoAlert UroToday.com KidneyCAN

Just in @Cancer_Cell 👉Validation of the molecular clusters of the IMmotion151 trial in the JAVELIN Renal 101 dataset #kidneycancer: Excellent commentary highlighting these biomarkers by our fellow @chadihc98 👇tinyurl.com/48px5rw8 @Huntsman_GU @OncoAlert @urotoday @kidneycan
account_circle
KidneyCAN(@kidneycan) 's Twitter Profile Photo

Our Town Hall is now available for you to watch!

Get the latest insights on clinical trials for kidney cancer from top experts and hear the powerful stories of patients. Plus, find all the links and resources mentioned during the event on our website.

bit.ly/RealTalkTrials

Our Town Hall is now available for you to watch! Get the latest insights on clinical trials for kidney cancer from top experts and hear the powerful stories of patients. Plus, find all the links and resources mentioned during the event on our website. bit.ly/RealTalkTrials
account_circle